64 related articles for article (PubMed ID: 737040)
1. [Use of an immunomodulator (levamisole) in HbsAg positive patients].
Milazzo F; Ghezzi E; Resta M; Brugo MA; Vitali D; Vigevani GM; Tassi GC
Boll Ist Sieroter Milan; 1978 Sep; 57(4):477-84. PubMed ID: 737040
[TBL] [Abstract][Full Text] [Related]
2. [Chronic persistent HBsAg positive hepatitis in children. II. Effect of treatment with levamisole].
Masi M; Paolucci P; Timoncini G; Fantini MP; Chiodo F; Franceschi C
Boll Ist Sieroter Milan; 1978 Sep; 57(4):471-6. PubMed ID: 310686
[TBL] [Abstract][Full Text] [Related]
3. Levamisole treatment of acute viral hepatitis and HBsAG-positive chronic active hepatitis.
Pár A; Barna K; Bajtai G; Hollós I; Ambrus M; Kovács M; Jávor T
Acta Med Acad Sci Hung; 1980; 37(3):269-81. PubMed ID: 7457030
[TBL] [Abstract][Full Text] [Related]
4. [Clinical, laboratory and liver histology of HBsAg-positive volunteer blood donors in Belo Horizonte, State of Minas Gerais, Brazil].
Paz MO; Galizzi Filho J; Simonetti JP; Simonetti SR; de Santana ZM; Barbosa MM; de Carvalho DG; Toppa NH
Rev Hosp Clin Fac Med Sao Paulo; 1998; 53(6):311-6. PubMed ID: 10413947
[TBL] [Abstract][Full Text] [Related]
5. Treatment of HBsAg-,HBeAg-positive chronic active hepatitis with adenine arabinoside. A case report with clinical remission and seroconversion to anti-HBs.
Loeschke K; Abb J; Farack UM; Wiebecke B
Hepatogastroenterology; 1985 Aug; 32(4):178-80. PubMed ID: 2865200
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory effects of HBsAg vaccine and levamisole in chronic hepatitis B and hepatitis B carrier children.
Demirci F; Bayraktaroğlu Z; Karaoğlan M; Coşkun Y; Karaoğlan I; Okan V
Turk J Gastroenterol; 2005 Dec; 16(4):188-93. PubMed ID: 16547845
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of type B and non-A, non-B hepatitis in hemophilia: relationship to chronic liver disease.
Kim HC; Saidi P; Ackley AM; Bringelsen KA; Gocke DJ
Gastroenterology; 1980 Dec; 79(6):1159-64. PubMed ID: 6777232
[TBL] [Abstract][Full Text] [Related]
8. Chronic delta hepatitis: a difficult problem for the hepatologist.
Picciotto A; Celle G
Hepatogastroenterology; 1984 Aug; 31(4):162-3. PubMed ID: 6383995
[TBL] [Abstract][Full Text] [Related]
9. Infection with hepatitis delta virus in patients with fulminant hepatitis B and chronic HBsAg carriers in Bulgaria.
Naoumov NV; Gueorgiev A; Ognyanov M; Maleev A
Hepatogastroenterology; 1986 Apr; 33(2):49-51. PubMed ID: 3721387
[TBL] [Abstract][Full Text] [Related]
10. Levamisole and interferon in children with chronic hepatitis B.
Ruiz-Moreno M; García R; Rua MJ; Serrano B; Moraleda G; Feijoo E; Bartolomé J; Ortiz F; Castillo I; Carreño V
Hepatology; 1993 Aug; 18(2):264-9. PubMed ID: 7687978
[TBL] [Abstract][Full Text] [Related]
11. [Hepatopathy and hepatitis B virus infection in dialysis patients: cross-sectional study].
Fabrizi F; Bisegna S; Mangano S; Alongi G; Colucci P; Finazzi S; De Vecchi AF; Ponticelli C
G Ital Nefrol; 2002; 19(2):149-54. PubMed ID: 12195413
[TBL] [Abstract][Full Text] [Related]
12. Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis.
Lam KC; Lai CL; Trepo C; Wu PC
N Engl J Med; 1981 Feb; 304(7):380-6. PubMed ID: 7005678
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
Gessoni G; Manoni F
Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245
[TBL] [Abstract][Full Text] [Related]
14. Chronic HBV infection. Immunomodulation with levamisole in viremic HBeAg positive or anti-HBe positive patients--a pilot study.
Krastev Z; Jelev D; Antonov K; Alagozian V; Kotzev I
Hepatogastroenterology; 1999; 46(30):3184-8. PubMed ID: 10626183
[TBL] [Abstract][Full Text] [Related]
15. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B.
Scullard GH; Smith CI; Merigan TC; Robinson WS; Gregory PB
Gastroenterology; 1981 Dec; 81(6):987-91. PubMed ID: 7286593
[TBL] [Abstract][Full Text] [Related]
16. Therapy for chronic hepatitis B with lymphoblastoid interferon-alpha and levamisole.
Fattovich G; Giustina G; Brollo L; Guido M; Pontisso P; Noventa F; Alberti A
Hepatology; 1992 Nov; 16(5):1115-9. PubMed ID: 1427652
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence and biochemical features of hepatitis B surface antigenemia in patients with HIV-1 infection in Lagos, Nigeria.
Iwalokun BA; Hodonu SO; Olaleye BM; Olabisi OA
Afr J Med Med Sci; 2006 Sep; 35(3):337-43. PubMed ID: 17312742
[TBL] [Abstract][Full Text] [Related]
18. Levamisole therapy for HBsAg-positive chronic liver disease.
Chadwick RG; Jain S; Cohen BJ; Scott GM; Thomas HC; Sherlock S
Scand J Gastroenterol; 1980; 15(8):973-8. PubMed ID: 6972083
[TBL] [Abstract][Full Text] [Related]
19. Two distinct types of hepatitis in experimental hepatitis B virus infection.
Shikata T; Karasawa T; Abe K
Am J Pathol; 1980 May; 99(2):353-68. PubMed ID: 7377287
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B surface antigen circulating immune complexes (HBsAg-CICs) in patients with hepatitis B and asymptomatic HBsAg carriers.
Anh-Tuan N; Novák E
Clin Exp Immunol; 1981 Feb; 43(2):246-53. PubMed ID: 7273479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
